Skip to main content
Log in

Variations in functioning and disability in multiple sclerosis

A two-year prospective study

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The aim of the present study was to explore variations in functioning and disability – with regard to cognition, manual dexterity, walking, energy, mood, activities of daily living and social/ lifestyle activities – every six months during a 2-year period, in 200 people with MS (PwMS) at an outpatient MS specialist clinic. Symbol Digit Modalities Test, Nine Hole Peg Test, Timed 25 Foot Walk, Fatigue Severity Scale, Beck Depression Inventory, Katz ADL Index Extended and Frenchay Activities Index were used to collect data. For analyses of statistically significant changes in scores during the study period, repeated measures ANOVA was used for ratio data and Friedman ANOVA for ordinal data. In addition, effect size as well as the mean/median change in score during the study period were determined for each functioning. Nearly all functioning studied varied significantly but there was no general deterioration in the sample. Small effect sizes were mainly found for the Frenchay Activities Index and a plausible practice effect was detected for the Symbol Digit Modalities Test. As many as 63 % with regard to walking and 46 % with regard to manual dexterity demonstrated > 20 % mean change in scores which has proved to be a reliable and clinically meaningful change. This study illustrates the importance of systematic and regular multidimensional assessment of functioning and disability in PwMS aiming to identify disabilities that could be minimized through timely and appropriate evidence-based interventions. The fluctuation in functioning and the conceivable learning effect inherent in instruments used should be taken into consideration when designing studies and interpreting the results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Amato M, Ponziani G, Siracusa G, Sorbi S (2001) Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 58:1602–1606

    Article  PubMed  CAS  Google Scholar 

  2. Arnett P, Randolph J (2006) Longitudinal course of depression symptoms in multiple sclerosis. J Neurol Neurosurg Psychiatry 77:606–610

    Article  PubMed  CAS  Google Scholar 

  3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    PubMed  CAS  Google Scholar 

  4. Bever CT Jr, Grattan L, Panitch HS, Johnson KP (1995) The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study. Mult Scler 1:165–169

    PubMed  Google Scholar 

  5. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH (2002) Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 159:1862–1868

    Article  PubMed  Google Scholar 

  6. Cohen J (1992) A power primer. Psychol Bull 112:155–159

    Article  Google Scholar 

  7. Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. N Engl J Med 343:1430–1438

    Article  PubMed  CAS  Google Scholar 

  8. Dent A, Lincoln NB (2000) Screening for memory problems in multiple sclerosis. Br J Clin Psychol 39:311–315

    Article  PubMed  Google Scholar 

  9. Einarsson U, Gottberg K, Fredriksson S, von Koch L, Widén Holmqvist L (2006) Activities of daily living and social activities in people with multiple sclerosis in Stockholm County. Clin Rehabil 20:543–551

    Article  PubMed  CAS  Google Scholar 

  10. Einarsson U, Gottberg K, von Koch L, Fredrikson S, Ytterberg C, Jin YP, et al. (2006) Cognitive and motor function in people with multiple sclerosis in Stockholm County. Mult Scler 12:340–353

    Article  PubMed  CAS  Google Scholar 

  11. Goldman Consensus Group (2005) The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 11:328–337

    Google Scholar 

  12. Goodkin DE, Hertsgaard D, Seminary J (1988) Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests. Arch Phys Med Rehabil 69:850–854

    PubMed  CAS  Google Scholar 

  13. Gottberg K, Einarsson U, Fredrikson S, von Koch L, Widen Holmqvist L (2007) A population-based study of depressive symptoms in multiple sclerosis in Stockholm County. Association with functioning and sense of coherence. J Neurol Neurosurg Psychiatry 78:60–65

    Article  PubMed  CAS  Google Scholar 

  14. Gulick E (1998) Symptom and activities of daily living trajectory in multiple sclerosis: a 10-year study. Nurs Res 47:137–146

    Article  PubMed  CAS  Google Scholar 

  15. Huber SJ, Rammohan KW, Bornstein RA, Christy JA (1993) Depression symptoms are not influenced by severity of multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol 6:177–180

    Google Scholar 

  16. Huijbregts S, Kalkers N, de Sonneville L, de Groot V, Polman C (2006) Cognitive impairment and decline in different subtypes. J Neurol Sci 245:187–194

    Article  PubMed  Google Scholar 

  17. Jenkinson C, Peto V, Jones G, Fitzpatrick R (2003) Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40). Clin Rehabil 17:380–385

    Article  PubMed  CAS  Google Scholar 

  18. Johnson K, Brooks B, Cohen J, Ford C, Goldstein J, Lisak R, et al. (1998) Copolymer 1 Multiple Sclerosis Study Group (2001) Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Neurology 57:46–53

    Google Scholar 

  19. Kaufman M, Moyer D, Norton J (2000) The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite. Mult Scler 6:286–290

    PubMed  CAS  Google Scholar 

  20. Kazis LE, Anderson JJ, Meenan R (1989) Effect sizes for interpreting changes in health status. Med Care 27(3 Suppl):178–189

    Article  Google Scholar 

  21. Kragt JJ, van der Linden FA, Nielsen, JM, Uitdehaag BM, Polman CH (2006) Clinical impact of 20 % worsening on Timed 25 %-foot Walk and 9-hole Peg Test in multiple sclerosis. Mult Scler 12:594–598

    Article  PubMed  CAS  Google Scholar 

  22. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45:435–437

    PubMed  CAS  Google Scholar 

  23. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123

    PubMed  CAS  Google Scholar 

  24. Kujala P, Portin R, Ruutiainen J (1997) The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain 120:289–297

    Article  PubMed  Google Scholar 

  25. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 77:1444–1452

    Google Scholar 

  26. Lerdal A, Celius EG, Moum T (2003) Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Mult Scler 9:509–514

    Article  PubMed  CAS  Google Scholar 

  27. Mathiowetz V, Weber K, Kashman N, Volland G (1985) Adult norms for the Nine Hole Peg Test of finger dexterity. Occup Ther J Res 5:24–38

    Google Scholar 

  28. Myhr KM, Riise T, Vedeler C, Nortvedt MW, Gronning R, Midgard R, et al. (2001) Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler 7:59–65

    PubMed  CAS  Google Scholar 

  29. Noseworthy JS (1994) Clinical scoring methods for multiple sclerosis. Ann Neurol 36 (Suppl):80–85

    Article  Google Scholar 

  30. Oberg T, Karsznia A, Oberg K (1993) Basic gait parameters: reference data for normal subjects, 10–79 years of age. J Rehabil Res Dev 30:210–223

    PubMed  CAS  Google Scholar 

  31. Patten SB, Beck CA, Williams JVA, Barbui C, Metz LM (2003) Major depression in multiple sclerosis: a population-based perspective. Neurology 61:1524–1527

    PubMed  CAS  Google Scholar 

  32. Peto V, Jenkinson C, Fitzpatrick R (2001) Determining minimally important differences for the PDQ-39 Parkinson’s disease questionnaire. Age Ageing 30:299–302

    Article  PubMed  CAS  Google Scholar 

  33. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, et al. (2004) Change in MSrelated disability in a populationbased cohort: a 10-year follow-up study. Neurology 62:51–59

    Article  PubMed  CAS  Google Scholar 

  34. Polman CH, O’Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, et al. ; AFFIRM investigators (2006) A randomized placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899–910

    Article  PubMed  CAS  Google Scholar 

  35. Poser C, Paty D, Scheinberg L, McDonald W, Davis F, Ebers G (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231

    Article  PubMed  CAS  Google Scholar 

  36. Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. Frequency, patterns, and prediction. Neurology 41:685–691

    PubMed  CAS  Google Scholar 

  37. Rietberg MB, Brooks D, Uitdehaag BMJ, Kwakkel G (2004) Exercise therapy for multiple sclerosis. Cochrane Database of Systematic (Reviews), Issue 3

  38. Rodriguez M, Siva A, Ward J, Stolp-Smith K, O’Brien P, Kurland L (1994) Impairment, disability, and handicap in multiple sclerosis: a populationbased study in Olmsted County, Minnesota. Neurology 44:28–33

    PubMed  CAS  Google Scholar 

  39. Rudick R, Goodkin D, Jacobs L, Cookfair D, Herndon R, Richert J, et al. (1997) Multiple Sclerosis Collaborative Research Group (2001) Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. Neurology 57:25–30

    Google Scholar 

  40. Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, et al. (1997) Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 42:379–382

    Article  PubMed  CAS  Google Scholar 

  41. Smith A (1982) Symbol Digit Modalities Test (SDMT). In: Lezak M (ed) Neuropsychological Assessment. 3rd ed. Oxford University Press, New York, pp 379–381

  42. Sonn U, Asberg KH (1991) Assessment of activities of daily living in the elderly. Scand J Rehab Med 23:193–202

    CAS  Google Scholar 

  43. Swingler RJ, Compston DA (1992) The morbidity of multiple sclerosis. Q J Med 83:325–337

    PubMed  CAS  Google Scholar 

  44. Tellez N, Rio J, Tintore M, Nos C, Galan I, Montalban X (2006) Fatigue in multiple sclerosis persists over time. A longitudinal study. J Neurol Nov 253:1466–1470

    Article  CAS  Google Scholar 

  45. The Swedish MS Association (2005) Sundstrom P, Vrethem M, Wallentin F, Myr A (Editorial Committee). Metodboken. http://www. mssallskapet. se Accessed March 5, 2007

  46. The Swedish MS-register http://www. msreg. net Accessed February 22, 2007

  47. Thomas PW, Thomas S, Hillier C, Galvin K, Baker R (2006) Psychological interventions for multiple sclerosis. Cochrane Database of Systematic (Reviews), Issue 1

  48. Tremlett H, Paty D, Devonshire V (2006) Disability progression in multiple sclerosis is slower than previously reported. Neurology 66:172–177

    Article  PubMed  Google Scholar 

  49. Turnbull JC, Kersten P, Habib M, McLellan L, Mullee MA, George S (2000) Validation of the Frenchay Activities Index in a general population aged 16 years and older. Arch Phys Med Rehabil 81:1034–1038

    Article  PubMed  CAS  Google Scholar 

  50. Wade DT, Legh-Smith J, Langton Hewer R (1985) Social activities after stroke: measurement and natural history using the Frenchay Activities Index. Int Rehabil Med 7:176–181

    PubMed  CAS  Google Scholar 

  51. World Health Organization (2001) International classification of functioning, disability and health www.who.int/classification/icf Accessed March 5, 2007

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Ytterberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ytterberg, C., Johansson, S., Andersson, M. et al. Variations in functioning and disability in multiple sclerosis. J Neurol 255, 967–973 (2008). https://doi.org/10.1007/s00415-008-0767-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0767-0

Key words

Navigation